FDA Device Intelligence
HomeDavol Inc. › HEMADERM

HEMADERM

Davol Inc. · Model ENT0001-2 · UDI-DI 00801741044083

NHBQSYLYA Prescription
1
510(k) clearances
178
Adverse events
15
Recalls
35
Facilities

Description

ENT Kit with HEMADERM, (Contents: 1) 2g bellows container and (Contents: 2) ENT Applicators

Recalls

DateFirmReason
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that
2025-02-25Stryker CorporationThere is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.